ARCHIVES

After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Grants Accelerated Approval to Mekinist-Tafinlar Combination

January 10, 2014

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

Congress Cuts $210 Million From NIH Budget For The Remainder of 2011

April 15, 2011

Ellen Stoval Calls For More Funding for All Cancer Research

June 6, 1997

Miami HIV Trials Unit Forced To Turn Some Patients Away

January 10, 1992

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000